Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#171 / 200 Total
BWEN - Broadwind Inc - Stock Price Chart
TickerBWEN [NASD]
CompanyBroadwind Inc
CountryUSA
IndustrySpecialty Industrial Machinery
Market Cap79.53MEPS (ttm)0.39
P/E9.42EPS this Y-69.44%
Forward P/E9.21EPS next Y261.36%
PEG0.39EPS past 5Y-
P/S0.41EPS next 5Y24.00%
P/B1.38EPS Q/Q92.22%
Dividend-Sales Q/Q-23.03%
Insider Own12.20%Inst Own27.22%
Insider Trans0.00%Inst Trans20.91%
Short Float0.99%EarningsMay 14/b
Analyst Recom1.00Target Price6.00
Avg Volume129.41K52W Range2.01 - 4.81
May-20-24 09:40AM Are Industrial Products Stocks Lagging Broadwind Energy (BWEN) This Year? (Zacks) +14.87%
08:50AM Why Fast-paced Mover Broadwind Energy (BWEN) Is a Great Choice for Value Investors (Zacks)
May-18-24 06:10AM Renewable Riches: 3 Stocks Harnessing the Power of Green Energy (InvestorPlace)
May-15-24 08:18AM Broadwind, Inc. (NASDAQ:BWEN) Q1 2024 Earnings Call Transcript (Insider Monkey) +6.97%
03:07AM Broadwind Inc (BWEN) Q1 2024 Earnings Call Transcript Highlights: Strategic Insights and ... (GuruFocus.com)
May-14-24 11:53AM BWEN Stock Earnings: Broadwind Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) +11.42%
08:15AM Broadwind Energy, Inc. (BWEN) Q1 Earnings and Revenues Beat Estimates (Zacks)
07:00AM Broadwind Announces First Quarter 2024 Results (GlobeNewswire)
May-10-24 03:40PM 3 Renewable Energy Stocks to Capitalize on the Sustainability Surge (InvestorPlace)
Apr-30-24 07:00AM Broadwind Announces First Quarter 2024 Results Conference Call and Webcast Date (GlobeNewswire)
CRBP - Corbus Pharmaceuticals Holdings Inc - Stock Price Chart
TickerCRBP [NASD]
CompanyCorbus Pharmaceuticals Holdings Inc
CountryUSA
IndustryBiotechnology
Market Cap495.48MEPS (ttm)-6.97
P/E-EPS this Y48.33%
Forward P/E-EPS next Y6.51%
PEG-EPS past 5Y18.86%
P/S-EPS next 5Y-
P/B5.02EPS Q/Q80.44%
Dividend-Sales Q/Q-
Insider Own1.08%Inst Own91.59%
Insider Trans-Inst Trans-80.73%
Short Float6.72%EarningsMay 07/b
Analyst Recom1.00Target Price71.00
Avg Volume290.13K52W Range3.03 - 49.87
May-17-24 04:12PM Google DeepMind CEO: 'This Is the Next $100 Billion AI Business' (InvestorPlace)
May-09-24 08:00AM Corbus Pharmaceuticals to Participate in the 2024 RBC Capital Markets Global Healthcare Conference (GlobeNewswire)
May-07-24 01:52PM CRBP Stock Earnings: Corbus Pharmaceuticals Beats EPS for Q1 2024 (InvestorPlace)
08:17AM Corbus Pharmaceuticals: Q1 Earnings Snapshot (Associated Press Finance)
08:00AM Corbus Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
May-06-24 02:06PM How the Medical Industry Could Produce the Biggest AI Stock Winners (InvestorPlace)
May-01-24 08:00AM Corbus Pharmaceuticals to Participate in the BTIG Obesity Health Forum (GlobeNewswire)
Apr-24-24 04:05PM Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO Annual Meeting (GlobeNewswire) -5.83%
Apr-19-24 02:30PM These 3 Small-Cap Stocks Are Up 304% in 2024. Can They Run Higher? (InvestorPlace) +7.42%
Apr-16-24 08:50AM Here's What Could Help Corbus Pharmaceuticals (CRBP) Maintain Its Recent Price Strength (Zacks)
COYA - Coya Therapeutics Inc - Stock Price Chart
TickerCOYA [NASD]
CompanyCoya Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap119.88MEPS (ttm)-0.92
P/E-EPS this Y-29.96%
Forward P/E-EPS next Y-49.51%
PEG-EPS past 5Y-
P/S19.56EPS next 5Y-
P/B3.68EPS Q/Q-27.01%
Dividend-Sales Q/Q-
Insider Own13.90%Inst Own31.70%
Insider Trans0.05%Inst Trans-
Short Float1.40%EarningsMay 09/a
Analyst Recom1.00Target Price15.67
Avg Volume90.03K52W Range3.21 - 10.69
May-20-24 09:10AM Coya Therapeutics Receives $5 Million Equity Investment from Alzheimer's Drug Discovery Foundation (MT Newswires)
08:15AM Coya Therapeutics Announces $5 Million Strategic Investment by the Alzheimer's Drug Discovery Foundation (ADDF) (Business Wire)
May-10-24 03:54PM Coya Therapeutics Reports First Quarter 2024 Financial Results (GuruFocus.com)
May-09-24 04:10PM Coya Therapeutics Provides a Corporate Update and Reports Unaudited First Quarter 2024 Financial Results (Business Wire) +5.35%
Apr-26-24 08:15AM Coya Therapeutics Presents Updated ALS Biomarker Data at the 2nd Annual Johnson Center Symposium (Business Wire)
Apr-22-24 08:15AM Coya Therapeutics to Participate in the Mizuho Neuroscience Summit (Business Wire)
Apr-18-24 08:15AM Coya Therapeutics to Participate in the 3rd Annual ALS Drug Development Summit (Business Wire)
Apr-08-24 08:15AM Coya Therapeutics Scientific Advisory Board Chairman Dr. Stanley Appel to Present Updated ALS Biomarker Data at the 2nd Annual Johnson Center Symposium (Business Wire)
Mar-21-24 05:31AM Coya Therapeutics Inc (COYA) Reports Fiscal 2023 Financial Results and Corporate Updates (GuruFocus.com)
Mar-19-24 09:53PM COYA Stock Earnings: Coya Therapeutics Reported Results for Q4 2023 (InvestorPlace)
CYTH - Cyclo Therapeutics Inc - Stock Price Chart
TickerCYTH [NASD]
CompanyCyclo Therapeutics Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap38.06MEPS (ttm)-1.00
P/E-EPS this Y46.34%
Forward P/E-EPS next Y6.57%
PEG-EPS past 5Y-88.22%
P/S33.68EPS next 5Y-
P/B62.38EPS Q/Q66.62%
Dividend-Sales Q/Q32.83%
Insider Own41.60%Inst Own10.74%
Insider Trans0.00%Inst Trans0.36%
Short Float0.33%EarningsMay 16/b
Analyst Recom1.00Target Price3.20
Avg Volume91.55K52W Range0.89 - 2.57
May-16-24 08:05AM Cyclo Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update (Business Wire)
07:53AM CYTH Stock Earnings: Cyclo Therapeutics Reported Results for Q1 2024 (InvestorPlace)
Mar-19-24 06:53AM CYTH Stock Earnings: Cyclo Therapeutics Reported Results for Q4 2023 (InvestorPlace)
Mar-18-24 09:05AM Cyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update (Business Wire)
Mar-14-24 09:34AM Cyclo Therapeutics Announces Issuance of U.S. Patent Covering the Use of Trappsol Cyclo for the Treatment of Alzheimers Disease (Business Wire)
Mar-13-24 05:04PM Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results (GlobeNewswire)
Jan-29-24 09:15AM Cyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimers Disease from the U.S. Patent and Trademark Office (Business Wire)
Dec-27-23 04:15PM Cyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc. (Business Wire) -7.87%
Dec-18-23 09:15AM Cyclo Therapeutics Announces Positive Outcome from Type C Meeting with the U.S. FDA Discussing Trappsol Cyclo Clinical Program for the Treatment of Niemann-Pick Disease Type C1 (Business Wire)
Dec-14-23 04:01PM Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results (GlobeNewswire)
CPOP - Pop Culture Group Co Ltd - Stock Price Chart
TickerCPOP [NASD]
CompanyPop Culture Group Co Ltd
CountryChina
IndustryEntertainment
Market Cap6.42MEPS (ttm)-1.79
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.21EPS next 5Y-
P/B0.16EPS Q/Q-394.74%
Dividend-Sales Q/Q113.30%
Insider Own28.25%Inst Own0.46%
Insider Trans0.00%Inst Trans-
Short Float0.33%Earnings-
Analyst Recom-Target Price-
Avg Volume1.97M52W Range0.91 - 9.67
May-09-24 12:43PM Top Midday Gainers (MT Newswires) +83.53%
11:02AM Why Is Pop Culture Group (CPOP) Stock Up 84% Today? (InvestorPlace)
07:54AM Top Premarket Gainers (MT Newswires)
07:29AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace)
May-08-24 04:05PM Pop Culture Announces Improvement in Overall Operations During the Six Months Ended December 31, 2023 (PR Newswire)
Feb-21-24 03:16PM 3 Stocks Most at Risk of a Catastrophic Collapse in 2024 (InvestorPlace) -13.49%
Jan-30-24 06:50AM 7 At-Risk Chinese Stocks to Sell Before They Slide (InvestorPlace) -5.67%
May-06-23 08:11AM Pop Culture Group First Half 2023 Earnings: US$0.20 loss per share (vs US$0.021 profit in 1H 2022) (Simply Wall St.)
Mar-01-23 09:30AM Pop Culture has Applied AIGC to Its Business System (PR Newswire)
Feb-15-23 08:00AM Pop Culture Group announces subsidiary's plan to accelerate digitization through ChatGPT (PR Newswire) +10.02%
GNPX - Genprex Inc - Stock Price Chart
TickerGNPX [NASD]
CompanyGenprex Inc
CountryUSA
IndustryBiotechnology
Market Cap4.93MEPS (ttm)-19.18
P/E-EPS this Y74.73%
Forward P/E-EPS next Y52.46%
PEG-EPS past 5Y8.89%
P/S-EPS next 5Y-
P/B0.52EPS Q/Q50.43%
Dividend-Sales Q/Q-
Insider Own2.28%Inst Own6.84%
Insider Trans0.00%Inst Trans27.89%
Short Float2.44%Earnings-
Analyst Recom1.00Target Price10.00
Avg Volume52.71K52W Range2.09 - 42.40
May-20-24 12:53PM GNPX Stock Earnings: Genprex Beats EPS for Q1 2024 (InvestorPlace)
May-15-24 04:42AM Genprex dosing subjects in trial of combination therapy for small-cell lung cancer (Clinical Trials Arena)
May-14-24 08:31AM Genprex Doses First Patient in Acclaim-3 Clinical Study of Reqorsa Immunogene Therapy in Combination with Tecentriq to Treat Small Cell Lung Cancer (PR Newswire) +7.53%
May-13-24 08:31AM Genprex Announces the Appointment of Jose A. Moreno Toscano as Chairman of the Board of Directors (PR Newswire)
May-08-24 06:08PM Genprex Announces the Passing of its Co-Founder and Chief Executive Officer, Rodney Varner (PR Newswire) -6.05%
May-07-24 09:15AM Sidoti Events, LLC's Virtual May Micro-Cap Conference (ACCESSWIRE) -5.13%
May-01-24 08:31AM Genprex to Present and Participate at Upcoming May Investor and Industry Conferences (PR Newswire)
Apr-09-24 08:31AM Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex Delivery System for the Treatment of Lung Cancers at the 2024 AACR Annual Meeting (PR Newswire)
Apr-04-24 08:57AM Genprex (GNPX) Expands SCLC Study of Key Candidate, Stock Up (Zacks)
Apr-03-24 08:31AM Genprex Expands Clinical Trial Sites for Acclaim-3 Clinical Study of Reqorsa Therapy in Combination with Tecentriq to Treat Small Cell Lung Cancer (PR Newswire) +9.51%
MYSZ - My Size Inc - Stock Price Chart
TickerMYSZ [NASD]
CompanyMy Size Inc
CountryIsrael
IndustrySoftware - Application
Market Cap2.90MEPS (ttm)-25.72
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y49.60%
P/S0.31EPS next 5Y-
P/B0.10EPS Q/Q-12.38%
Dividend-Sales Q/Q314.44%
Insider Own28.35%Inst Own8.11%
Insider Trans-2.52%Inst Trans-
Short Float6.42%EarningsMay 16/b
Analyst Recom1.00Target Price12.00
Avg Volume79.48K52W Range2.88 - 21.92
May-16-24 09:00AM MySize Reports First Quarter 2024 Financial Results: Record Three-Month Revenues and Gross Profits (PR Newswire)
May-07-24 10:08AM My Size Regains Compliance with Nasdaq Minimum Closing Bid Price Rule (PR Newswire) -6.69%
Apr-15-24 04:15PM My Size Announces Reverse Stock Split (PR Newswire)
Apr-02-24 09:52AM MYSZ Stock Earnings: My Size Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace)
Feb-22-24 09:00AM Naiz Fit, a My Size Inc Company, Unveils Groundbreaking Generative AI Strategies to Revolutionize Fashion Tech (PR Newswire)
Jan-11-24 09:00AM MySize to Exhibit at National Retail Federation 2024 in New York City (PR Newswire) -6.05%
Dec-05-23 09:00AM Fox Business Network TV show, Varney and Company Interviews MySize CEO Ronen Luzon (PR Newswire)
Nov-15-23 09:00AM MySize Reports Third Quarter 2023 Financial Results: Record Nine-Month Revenues and Gross Profits (PR Newswire)
Nov-02-23 12:00PM MySize's Naiz Fit Launches New Product for $33 Billion Workwear & Uniforms Market -- Several New Clients Signed (PR Newswire) +17.21%
Oct-30-23 08:30AM MySize Issues Shareholder Update: Revised 2023 Revenue Guidance of ~ $8 Million (PR Newswire) +15.00%
RLAY - Relay Therapeutics Inc - Stock Price Chart
TickerRLAY [NASD, RUT]
CompanyRelay Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap1.00BEPS (ttm)-2.64
P/E-EPS this Y-1.73%
Forward P/E-EPS next Y0.65%
PEG-EPS past 5Y-38.74%
P/S28.31EPS next 5Y-
P/B1.34EPS Q/Q19.93%
Dividend-Sales Q/Q4327.88%
Insider Own29.45%Inst Own72.51%
Insider Trans-0.05%Inst Trans1.46%
Short Float12.64%EarningsMay 02/a
Analyst Recom1.09Target Price23.10
Avg Volume1.24M52W Range5.70 - 13.32
May-13-24 08:30AM Relay Therapeutics to Host New Program and Platform Event on June 6, 2024 (GlobeNewswire)
May-10-24 10:01AM Barclays Upgrades Relay Therapeutics to Overweight From Equalweight With $15 Price Target (MT Newswires)
May-06-24 08:57AM Oppenheimer Adjusts Relay Therapeutics Price Target to $25 From $33, Maintains Outperform Rating (MT Newswires)
May-02-24 09:55PM RLAY Stock Earnings: Relay Therapeutics Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) +6.31%
05:55PM Relay Therapeutics Outperforms Revenue Expectations in Q1 2024 (GuruFocus.com)
05:40PM Relay Therapeutics, Inc. (RLAY) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate Highlights (GlobeNewswire)
Apr-25-24 04:05PM Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024 (GlobeNewswire)
Apr-11-24 04:05PM Relay Therapeutics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Mar-17-24 05:20PM 11 Oversold Biotech Stocks To Buy Right Now (Insider Monkey)
ALIM - Alimera Sciences Inc. - Stock Price Chart
TickerALIM [NASD]
CompanyAlimera Sciences Inc.
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap163.72MEPS (ttm)-1.57
P/E-EPS this Y91.14%
Forward P/E16.45EPS next Y371.43%
PEG-EPS past 5Y21.42%
P/S1.81EPS next 5Y-
P/B4.03EPS Q/Q83.77%
Dividend-Sales Q/Q69.87%
Insider Own9.92%Inst Own83.47%
Insider Trans0.00%Inst Trans0.45%
Short Float0.26%EarningsMay 14/b
Analyst Recom1.00Target Price8.00
Avg Volume68.11K52W Range2.27 - 4.38
May-15-24 03:06AM Alimera Sciences Inc (ALIM) Q1 2024 Earnings Call Transcript Highlights: Soaring Revenues and ... (GuruFocus.com)
May-14-24 11:53AM ALIM Stock Earnings: Alimera Sciences Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace) -5.75%
08:40AM Alimera Sciences (ALIM) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
07:38AM Alimera Sciences: Q1 Earnings Snapshot (Associated Press Finance)
07:30AM Alimera Sciences Reports First Quarter 2024 Results (GlobeNewswire)
May-07-24 08:00AM Alimera Announces Scientific Data Highlighting YUTIQ to be Presented at Upcoming Association for Research in Vision and Ophthalmology and Retina World Congress Conferences (GlobeNewswire)
Apr-30-24 08:00AM Alimera Sciences to Report First Quarter 2024 Financial Results on May 14, 2024, and Provide Corporate Update (GlobeNewswire)
Mar-20-24 08:00AM Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Mar-19-24 08:00AM Alimera Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRCR Retina Network (GlobeNewswire)
Mar-08-24 10:05AM Alimera Sciences, Inc. (NASDAQ:ALIM) Q4 2023 Earnings Call Transcript (Insider Monkey)
LRHC - La Rosa Holdings Corp - Stock Price Chart
TickerLRHC [NASD]
CompanyLa Rosa Holdings Corp
CountryUSA
IndustryReal Estate Services
Market Cap19.86MEPS (ttm)-0.86
P/E-EPS this Y-557.10%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.62EPS next 5Y-
P/B2.48EPS Q/Q-719.00%
Dividend-Sales Q/Q90.00%
Insider Own53.98%Inst Own0.15%
Insider Trans0.00%Inst Trans-
Short Float0.36%Earnings-
Analyst Recom-Target Price-
Avg Volume557.65K52W Range0.90 - 5.53
Today 08:30AM La Rosa Appoints Corporate Finance Executive Lourdes Felix to its Board of Directors (GlobeNewswire) +7.20%
May-16-24 08:53AM LRHC Stock Earnings: La Rosa Holdings Reported Results for Q1 2024 (InvestorPlace) -7.69%
08:30AM La Rosa Reports 117% Year-Over-Year Increase in Revenue to $13.1 Million for the First Quarter of 2024 (GlobeNewswire)
May-10-24 10:16AM New to The Street Airs Corporate Interviews, Televised Episodes 573 and 574 as Sponsored Programming on Bloomberg TV and The FOX Business Network (GlobeNewswire) -10.10%
May-06-24 09:30AM New to The Street Airs Episode 572 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network, Monday, May 6, 2024, at 10:30 PM PT (GlobeNewswire)
May-02-24 09:30AM New to The Street TV Announces the Interviews of Five Corporate Guest, Episode 571, Airing on Bloomberg TV as Sponsored Programming, Tonight, Thursday, May 2, 2024, 9:30 PM PT (GlobeNewswire) +6.33%
Apr-29-24 09:00AM Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV (ACCESSWIRE)
Apr-26-24 09:15AM New to The Street Announces Five Corporate Interviews, Televised Episode 570 Airs as Sponsored Programming on Bloomberg TV on Saturday, April 27, 2024, at 6:30 PM ET (GlobeNewswire)
Apr-25-24 08:30AM La Rosa Acquires Tenth Real Estate Brokerage Franchisee with Revenue of $4.7 Million and Positive Net Income in 2023 (GlobeNewswire) +6.88%
Apr-23-24 08:30AM La Rosa to Present at the Planet MicroCap Showcase: VEGAS 2024 on May 1, 2024 (ACCESSWIRE)
1⋯10⋯1314151617181920
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.